BERARDELLI, RITA
 Distribuzione geografica
Continente #
NA - Nord America 2.124
EU - Europa 1.159
AS - Asia 537
SA - Sud America 20
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.860
Nazione #
US - Stati Uniti d'America 2.089
CN - Cina 333
SE - Svezia 236
IT - Italia 171
IE - Irlanda 146
UA - Ucraina 146
FI - Finlandia 89
FR - Francia 85
DE - Germania 81
KR - Corea 74
PL - Polonia 50
VN - Vietnam 38
GB - Regno Unito 36
CA - Canada 34
NL - Olanda 26
AT - Austria 21
JP - Giappone 19
PH - Filippine 17
GR - Grecia 14
BE - Belgio 13
DK - Danimarca 13
IN - India 12
BR - Brasile 9
UZ - Uzbekistan 9
AR - Argentina 8
AU - Australia 8
RU - Federazione Russa 8
ES - Italia 7
LB - Libano 7
IR - Iran 5
RS - Serbia 5
SG - Singapore 5
TR - Turchia 4
TW - Taiwan 4
EG - Egitto 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
CY - Cipro 2
GY - Guiana 2
HK - Hong Kong 2
HR - Croazia 2
NZ - Nuova Zelanda 2
CH - Svizzera 1
CO - Colombia 1
ID - Indonesia 1
KH - Cambogia 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
SD - Sudan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.860
Città #
Chandler 397
Beijing 258
Houston 216
Dublin 146
Dearborn 113
Ann Arbor 109
Fairfield 77
Ashburn 74
Jacksonville 68
Wilmington 68
Nyköping 66
Torino 54
Princeton 48
Villeurbanne 43
Warsaw 40
Medford 39
Woodbridge 39
Seattle 35
Redwood City 30
Pisa 29
Cambridge 27
Boston 23
Fremont 22
Toronto 22
New York 21
Vienna 21
San Mateo 19
Munich 16
Dong Ket 15
Boardman 14
Norwalk 11
Brussels 10
Nanjing 10
Milan 9
Portland 9
Guangzhou 8
Kunming 8
Hefei 7
Silver Spring 7
Washington 7
Paris 6
Phoenix 6
Belgrade 5
Brisbane 5
Pune 5
Shanghai 5
Athens 4
Barcelona 4
Buffalo 4
Falls Church 4
Jinan 4
Kharkiv 4
Leiden 4
Munro 4
Newcastle upon Tyne 4
San Diego 4
Shenyang 4
Taipei 4
Tokyo 4
Verona 4
Ashland 3
Castellammare di Stabia 3
Chengdu 3
Chicago 3
Helsinki 3
Lachine 3
New Rochelle 3
Pittsburgh 3
Polska 3
Rome 3
Shrewsbury 3
Vancouver 3
Ankara 2
Buenos Aires 2
Changchun 2
Copenhagen 2
Curitiba 2
Demotte 2
Frankfurt am Main 2
Fuzhou 2
Georgetown 2
Hong Kong 2
Miller Place 2
Mountain View 2
Osaka 2
Ottawa 2
Randolph 2
Randolph Township 2
Redmond 2
Romainville 2
Rotterdam 2
San Francisco 2
Seo-gu 2
Serra 2
Seyssel 2
Shoreham 2
Suita 2
Szczecin 2
Tappahannock 2
Tourcoing 2
Totale 2.415
Nome #
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 325
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE 278
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 240
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 215
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 165
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 125
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS 106
Secondary adrenal insufficiency: Where is it hidden and what does it look like? 104
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 104
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 95
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE 95
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 93
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 93
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 90
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 78
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 75
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 75
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 74
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 74
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 73
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 72
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE 70
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 67
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 67
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 64
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 63
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 62
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 62
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 62
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 61
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 60
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? 60
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 59
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 57
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 57
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 56
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 56
Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine disease: evidence for subclinical primary hypoadrenalism? 56
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer 54
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), in anorexia nervosa. 53
SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS 51
Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. 46
Lenvatinib in advanced radioiodine-refractory thyroid cancer: A snapshot of real-life clinical practice 44
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 43
WRIST ACTIGRAPHY REVEALS SLEEP DISTURBANCES IN PATIENTS WITH CUSHING’S DISEASE 34
Totale 4.013
Categoria #
all - tutte 10.067
article - articoli 0
book - libri 0
conference - conferenze 3.444
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019138 0 0 0 0 0 0 0 0 0 28 80 30
2019/2020694 20 9 17 75 50 236 101 41 35 51 42 17
2020/2021451 50 45 17 18 64 12 42 39 33 36 36 59
2021/2022612 14 12 15 49 40 24 78 42 26 85 124 103
2022/2023905 89 89 28 114 71 233 46 52 96 32 38 17
2023/2024254 55 55 27 16 17 52 5 14 2 11 0 0
Totale 4.013